ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda’s dengue vaccine bags positive long-term efficacy results
May 26, 2021Japanese pharma company Takeda has announced that its dengue vaccine candidate TAK-003 demonstrated continued protection through three years after vaccination, regardless of previous exposure to the disease. -
EMA accepts regulatory submission for Takeda’s dengue vaccine candidate
March 29, 2021The submission is the first in a series that will include dengue-endemic countries, it includes long-term Phase III safety and efficacy data for the TAK-003 vaccine candidate. -
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
March 16, 2021Takeda Pharmaceutical has entered a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization (CDMO), to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture ...
Pharma Sources Insight January 2025
